Cancer cell survival during detachment from the ECM: Multiple barriers to tumour progression

Nature Reviews Cancer

Volumn 14, Issue 9, 2014, Pages 632-641

  Buchheit, Cassandra L ^a   Weigel, Kelsey J ^a   Schafer, Zachary T ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANOIKIS; AUTOPHAGY; CANCER CELL; CANCER CONTROL; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANOIKIS; CELL SURVIVAL; EXTRACELLULAR MATRIX; HUMANS; NEOPLASMS;

EID: 84906936187     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3789     Document Type: Review

References (149)

1. Sethi, N. & Kang, Y. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nature Rev. Cancer 11, 735-748 (2011
2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011
3. Nguyen, D. X. & Massague, J. Genetic determinants of cancer metastasis. Nature Rev. Genet. 8, 341-352 (2007
4. Mehlen, P. & Puisieux, A. Metastasis: A question of life or death. Nature Rev. Cancer 6, 449-458 (2006
5. Frisch, S. M. & Screaton, R. A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562 (2001
6. Simpson, C. D., Anyiwe, K. & Schimmer, A. D. Anoikis resistance and tumor metastasis. Cancer Lett. 272, 177-185 (2008
7. Buchheit, C. L., Rayavarapu, R. R. & Schafer, Z. T. The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin. Cell Dev. Biol. 23, 402-411 (2012
8. Gschwind, A., Fischer, O. M. & Ullrich, A. The discovery of receptor tyrosine kinases: Targets for cancer therapy. Nature Rev. Cancer 4, 361-370 (2004
9. Resnicoff, M. et al. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54, 4848-4850 (1994
10. Reiss, K., D'Ambrosio, C., Tu, X., Tu, C. & Baserga, R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res. 4, 2647-2655 (1998
11. Dunn, S. E. et al. A dominant negative mutant of the insulin-like growth factor I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 58, 3353-3361 (1998
12. Pollak, M. The insulin and insulin-like growth factor receptor family in neoplasia: An update. Nature Rev. Cancer 12, 159-169 (2012
13. Martin, M. J. et al. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6 NTRK3 chimeric tyrosine kinase. Mol. Cell. Biol. 26, 1754-1769 (2006
14. Irie, H. Y. et al. PTK6 regulates IGF 1 induced anchorage-independent survival. PLoS ONE 5, e11729 (2010
15. Debnath, J. et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40 (2002
16. Reginato, M. J. et al. Integrins and EGFR coordinately regulate the pro-Apoptotic protein Bim to prevent anoikis. Nature Cell Biol. 5, 733-740 (2003
17. Reginato, M. J. et al. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol. Cell. Biol. 25, 4591-4601 (2005
18. Grassian, A. R., Schafer, Z. T. & Brugge, J. S. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J. Biol. Chem. 286, 79-90 (2011
19. Haenssen, K. K. et al. ErbB2 requires integrin α5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J. Cell Sci. 123, 1373-1382 (2010
20. Giannoni, E., Buricchi, F., Raugei, G., Ramponi, G. & Chiarugi, P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol. 25, 6391-6403 (2005
21. Boerner, J. L., Demory, M. L., Silva, C. & Parsons, S. J. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol. Cell. Biol. 24, 7059-7071 (2004
22. Giannoni, E. et al. Redox regulation of anoikis: Reactive oxygen species as essential mediators of cell survival. Cell Death Differ. 15, 867-878 (2008
23. Giannoni, E., Fiaschi, T., Ramponi, G. & Chiarugi, P. Redox regulation of anoikis resistance of metastatic prostate cancer cells: Key role for Src and EGFR-mediated pro-survival signals. Oncogene 28, 2074-2086 (2009
24. Zhu, P. et al. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19, 401-415 (2011
25. Schafer, Z. T. et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109-113 (2009
26. Whelan, K. A. et al. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Mol. Biol. Cell 21, 3829-3837 (2010
27. Whelan, K. A. et al. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF 1 for mammary tumor growth and anoikis resistance. J. Biol. Chem. 288, 15865-15877 (2013
28. Fukazawa, H., Noguchi, K., Masumi, A., Murakami, Y. & Uehara, Y. BimEL is an important determinant for induction of anoikis sensitivity by mitogen-Activated protein/extracellular signal-regulated kinase kinase inhibitors. Mol. Cancer Ther. 3, 1281-1288 (2004
29. Schmelzle, T. et al. Functional role and oncogene-regulated expression of the BH3 only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc. Natl Acad. Sci. USA 104, 3787-3792 (2007
30. Yu, M. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510-513 (2012
31. Carduner, L. et al. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids. Exp. Cell Res. 320, 329-342 (2014
32. Attwell, S., Roskelley, C. & Dedhar, S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19, 3811-3815 (2000
33. Weigel, K. J. et al. CAF-secreted IGFBPs regulate breast cancer cell anoikis. Mol. Cancer Res. 12, 855-866 (2014
34. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nature Rev. Cancer 3, 11-22 (2003
35. Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626 (1994
36. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3 OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793 (1997
37. Rytomaa, M., Lehmann, K. & Downward, J. Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: Inhibition by PKB/Akt but not Raf signalling. Oncogene 19, 4461-4468 (2000
38. Rosen, K. et al. Activated Ras prevents downregulation of Bcl XL triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J. Cell Biol. 149, 447-456 (2000
39. Yoo, B. H. et al. Oncogenic ras-induced down-regulation of pro-Apoptotic protease caspase 2 is required for malignant transformation of intestinal epithelial cells. J. Biol. Chem. 286, 38894-38903 (2011
40. Fukazawa, H. & Uehara, Y. U0126 reverses Ki ras-mediated transformation by blocking both mitogen-Activated protein kinase and p70 S6 kinase pathways. Cancer Res. 60, 2104-2107 (2000
41. McFall, A. et al. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3 kinase. Mol. Cell. Biol. 21, 5488-5499 (2001
42. Eckert, L. B. et al. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res. 64, 4585-4592 (2004
43. Le Gall, M. et al. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 11, 1103-1112 (2000
44. Becker, T. M. et al. Oncogenic B RAFV600E promotes anchorage-independent survival of human melanocytes. J. Invest. Dermatol. 130, 2144-2147 (2010
45. Marani, M. et al. Role of Bim in the survival pathway induced by Raf in epithelial cells. Oncogene 23, 2431-2441 (2004
46. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002
47. Boisvert-Adamo, K. & Aplin, A. E. B RAF and PI 3 kinase signaling protect melanoma cells from anoikis. Oncogene 25, 4848-4856 (2006
48. Boisvert-Adamo, K. & Aplin, A. E. Mutant B RAF mediates resistance to anoikis via Bad and Bim. Oncogene 27, 3301-3312 (2008
49. Boisvert-Adamo, K., Longmate, W., Abel, E. V. & Aplin, A. E. Mcl 1 is required for melanoma cell resistance to anoikis. Mol. Cancer Res. 7, 549-556 (2009
50. Becker, T. M. et al. Mutant B RAF-Mcl 1 survival signaling depends on the STAT3 transcription factor. Oncogene 33, 1158-1166 (2014
51. Sahai, E. & Marshall, C. J. RHO-GTPases and cancer. Nature Rev. Cancer 2, 133-142 (2002
52. Bharadwaj, S., Thanawala, R., Bon, G., Falcioni, R. & Prasad, G. L. Resensitization of breast cancer cells to anoikis by tropomyosin 1: Role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene 24, 8291-8303 (2005
53. Ma, Z., Myers, D. P., Wu, R. F., Nwariaku, F. E. & Terada, L. S. p66Shc mediates anoikis through RhoA. J. Cell Biol. 179, 23-31 (2007
54. Li, X. et al. Aiolos promotes anchorage independence by silencing p66Shc transcription in cancer cells. Cancer Cell 25, 575-589 (2014
55. Ma, Z., Liu, Z., Wu, R. F. & Terada, L. S. p66Shc restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene 29, 5559-5567 (2010
56. Jiang, K. et al. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol. Cell. Biol. 24, 5565-5576 (2004
57. Cai, J. et al. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia 10, 41-51 (2008
58. Goundiam, O., Nagel, M. D. & Vayssade, M. Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cells. Cell Biol. Int. 36, 311-319 (2012
59. Yamaki, N., Negishi, M. & Katoh, H. RhoG regulates anoikis through a phosphatidylinositol 3 kinase-dependent mechanism. Exp. Cell Res. 313, 2821-2832 (2007
60. Harada, K., Hiramoto-Yamaki, N., Negishi, M. & Katoh, H. Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3 kinase. Exp. Cell Res. 317, 1701-1713 (2011
61. Frisch, S. M., Schaller, M. & Cieply, B. Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J. Cell Sci. 126, 21-29 (2013
62. Derksen, P. W. et al. Somatic inactivation of E cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437-449 (2006
63. Onder, T. T. et al. Loss of E cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68, 3645-3654 (2008
64. Kumar, S. et al. A pathway for the control of anoikis sensitivity by E cadherin and epithelial-To mesenchymal transition. Mol. Cell. Biol. 31, 4036-4051 (2011
65. Schackmann, R. C. et al. Loss of p120 catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. Cancer Res. 73, 4937-4949 (2013
66. Jia, J. et al. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma. PLoS ONE 7, e51549 (2012
67. Douma, S. et al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430, 1034-1039 (2004
68. Geiger, T. R. & Peeper, D. S. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res. 67, 6221-6229 (2007
69. Smit, M. A., Geiger, T. R., Song, J. Y., Gitelman, I. & Peeper, D. S. A. Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol. Cell. Biol. 29, 3722-3737 (2009
70. Chen, N. et al. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. Cancer Discov. 3, 1172-1189 (2013
71. White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nature Rev. Cancer 12, 401-410 (2012
72. Levine, B. & Yuan, J. Autophagy in cell death: An innocent convict?. J. Clin. Invest. 115, 2679-2688 (2005
73. Mills, K. R., Reginato, M., Debnath, J., Queenan, B. & Brugge, J. S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc. Natl Acad. Sci. USA 101, 3438-3443 (2004
74. Fung, C., Lock, R., Gao, S., Salas, E. & Debnath, J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 19, 797-806 (2008
75. Avivar-Valderas, A. et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell. Biol. 31, 3616-3629 (2011
76. Avivar-Valderas, A. et al. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 32, 4932-4940 (2013
77. Chen, N. & Debnath, J. I?B kinase complex (IKK) triggers detachment-induced autophagy in mammary epithelial cells independently of the PI3K AKT MTORC1 pathway. Autophagy 9, 1214-1227 (2013
78. Altman, B. J. & Rathmell, J. C. Metabolic stress in autophagy and cell death pathways. Cold Spring Harb. Perspect. Biol. 4, a008763 (2012
79. Jin, S., DiPaola, R. S., Mathew, R. & White, E. Metabolic catastrophe as a means to cancer cell death. J. Cell Sci. 120, 379-383 (2007
80. Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nature Rev. Cancer 11, 85-95 (2011
81. Buchakjian, M. R. & Kornbluth, S. The engine driving the ship: Metabolic steering of cell proliferation and death. Nature Rev. Mol. Cell Biol. 11, 715-727 (2010
82. Pandolfi, P. P. et al. Targeted disruption of the housekeeping gene encoding glucose 6 phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14, 5209-5215 (1995
83. Davison, C. A. et al. Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. Cancer Res. 73, 3704-3715 (2013
84. Grassian, A. R., Metallo, C. M., Coloff, J. L., Stephanopoulos, G. & Brugge, J. S. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev. 25, 1716-1733 (2011
85. Locasale, J. W. et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature Genet. 43, 869-874 (2011
86. DeNicola, G. M. et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106-109 (2011
87. Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell in cell invasion. Cell 131, 966-979 (2007
88. Wan, Q. et al. Regulation of myosin activation during cell-cell contact formation by Par3 Lgl antagonism: Entosis without matrix detachment. Mol. Biol. Cell 23, 2076-2091 (2012
89. Wang, S. et al. Internalization of NK cells into tumor cells requires ezrin and leads to programmed cell in cell death. Cell Res. 19, 1350-1362 (2009
90. Wen, S., Shang, Z., Zhu, S., Chang, C. & Niu, Y. Androgen receptor enhances entosis, a non-Apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells. Prostate 73, 1306-1315 (2013
91. Overholtzer, M. & Brugge, J. S. The cell biology of cell in cell structures. Nature Rev. Mol. Cell Biol. 9, 796-809 (2008
92. Florey, O., Kim, S. E., Sandoval, C. P., Haynes, C. M. & Overholtzer, M. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nature Cell Biol. 13, 1335-1343 (2011
93. Krajcovic, M., Krishna, S., Akkari, L. & Joyce, J. A. & Overholtzer, M. mTOR regulates phagosome and entotic vacuole fission. Mol. Biol. Cell 24, 3736-3745 (2013
94. Arteaga, C. L. et al. Treatment of HER2 positive breast cancer: Current status and future perspectives. Nature Rev. Clin. Oncol. 9, 16-32 (2012
95. Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J. & Brugge, J. S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nature Cell Biol. 3, 785-792 (2001
96. Debnath, J. & Brugge, J. S. Modelling glandular epithelial cancers in three-dimensional cultures. Nature Rev. Cancer 5, 675-688 (2005
97. Mailleux, A. A. et al. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev. Cell 12, 221-234 (2007
98. Collins, N. L. et al. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol. Cell. Biol. 25, 5282-5291 (2005
99. Virnig, B. A., Tuttle, T. M., Shamliyan, T. & Kane, R. L. Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes. J. Natl Cancer Inst. 102, 170-178 (2010
100. Rosenblatt, J., Raff, M. C. & Cramer, L. P. An epithelial cell destined for apoptosis signals its neighbors to extrude it by an actin-And myosin-dependent mechanism. Curr. Biol. 11, 1847-1857 (2001
101. Valentinis, B., Reiss, K. & Baserga, R. Insulin-like growth factor-I mediated survival from anoikis: Role of cell aggregation and focal adhesion kinase. J. Cell. Physiol. 176, 648-657 (1998
102. Rosen, K., Coll, M. L., Li, A. & Filmus, J. Transforming growth factor-α prevents detachment-induced inhibition of c Src kinase activity, Bcl XL down-regulation, and apoptosis of intestinal epithelial cells. J. Biol. Chem. 276, 37273-37279 (2001
103. Wen, H. C. et al. p38α signaling induces anoikis and lumen formation during mammary morphogenesis. Sci. Signal. 4, ra34 (2011
104. Coll, M. L., Rosen, K., Ladeda, V. & Filmus, J. Increased Bcl xL expression mediates v Src-induced resistance to anoikis in intestinal epithelial cells. Oncogene 21, 2908-2913 (2002
105. Rosen, K., Shi, W., Calabretta, B. & Filmus, J. Cell detachment triggers p38 mitogen-Activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of Anoikis of intestinal epithelial cells. J. Biol. Chem. 277, 46123-46130 (2002
106. Owens, T. W. et al. Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38MAPK. Cell Death Differ. 16, 1551-1562 (2009
107. Frisch, S. M., Vuori, K., Ruoslahti, E. & Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799 (1996
108. Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W. & Whang, E. E. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 135, 555-562 (2004
109. Kamarajan, P. & Kapila, Y. L. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin α v levels and phosphorylation of FAK and ERK. Apoptosis 12, 2221-2231 (2007
110. Zhang, Y., Lu, H., Dazin, P. & Kapila, Y. Squamous cell carcinoma cell aggregates escape suspension-induced, 53 mediated anoikis: Fibronectin and integrin αv mediate survival signals through focal adhesion kinase. J. Biol. Chem. 279, 48342-48349 (2004
111. Sakamoto, S., McCann, R. O., Dhir, R. & Kyprianou, N. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res. 70, 1885-1895 (2010
112. Zouq, N. K. et al. FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: Differential roles for paxillin and p130Cas. J. Cell Sci. 122, 357-367 (2009
113. Zheng, Y. et al. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT. Oncogene 32, 4304-4312 (2013
114. Windham, T. C. et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene 21, 7797-7807 (2002
115. Wei, L., Yang, Y., Zhang, X. & Yu, Q. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 23, 9052-9061 (2004
116. Thapa, N., Choi, S., Hedman, A., Tan, X. & Anderson, R. A. Phosphatidylinositol phosphate 5 kinase Iγi2 in association with Src controls anchorage-independent growth of tumor cells. J. Biol. Chem. 288, 34707-34718 (2013
117. Persad, S. et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc. Natl Acad. Sci. USA 97, 3207-3212 (2000
118. Liu, S. G. et al. Atypical protein kinase Ciota (PKCiota) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCiota SKP2 AKT pathway. Mol. Cancer Res. 9, 390-402 (2011
119. Ivanova, I. A. et al. FER kinase promotes breast cancer metastasis by regulating α6-And β1 integrin-dependent cell adhesion and anoikis resistance. Oncogene 32, 5582-5592 (2013
120. Jin, L. et al. p90 RSK2 mediates antianoikis signals by both transcription-dependent and-independent mechanisms. Mol. Cell. Biol. 33, 2574-2585 (2013
121. Rosen, K. et al. Downregulation of the pro-Apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr. Biol. 8, 1331-1334 (1998
122. Liu, Z. et al. Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-Apoptotic protein Omi/HtrA2 into the cytoplasm. J. Biol. Chem. 281, 14738-14747 (2006
123. Liu, Z. et al. ras oncogene triggers up regulation of cIAP2 and XIAP in intestinal epithelial cells: Epidermal growth factor receptor-dependent and-independent mechanisms of ras-induced transformation. J. Biol. Chem. 280, 37383-37392 (2005
124. Schulze, A., Lehmann, K., Jefferies, H. B., McMahon, M. & Downward, J. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev. 15, 981-994 (2001
125. Aoudjit, F. & Vuori, K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: A role for c flip and implications for anoikis. J. Cell Biol. 152, 633-643 (2001
126. Jiang, K., Delarue, F. L. & Sebti, S. M. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Oncogene 23, 1136-1145 (2004
127. Schackmann, R. C. et al. Cytosolic p120 catenin regulates growth of metastatic lobular carcinoma through Rock1 mediated anoikis resistance. J. Clin. Invest. 121, 3176-3188 (2011
128. Vigil, D. et al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res. 72, 5338-5347 (2012
129. Coniglio, S. J., Jou, T. S. & Symons, M. Rac1 protects epithelial cells against anoikis. J. Biol. Chem. 276, 28113-28120 (2001
130. Cheng, T. L., Symons, M. & Jou, T. S. Regulation of anoikis by Cdc42 and Rac1. Exp. Cell Res. 295, 497-511 (2004
131. Yu, S. J. et al. MicroRNA 200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer. Clin. Cancer Res. 19, 1389-1399 (2013
132. Vigneron, A. M., Ludwig, R. L. & Vousden, K. H. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes Dev. 24, 2430-2439 (2010
133. Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54-68 (2012
134. Efklidou, S., Bailey, R., Field, N., Noursadeghi, M. & Collins, M. K. vFLIP from KSHV inhibits anoikis of primary endothelial cells. J. Cell Sci. 121, 450-457 (2008
135. Toruner, M. et al. Antianoikis effect of nuclear factor-?B through up regulated expression of osteoprotegerin, BCL 2, and IAP 1. J. Biol. Chem. 281, 8686-8696 (2006
136. Mehrotra, S. et al. IAP regulation of metastasis. Cancer Cell 17, 53-64 (2010
137. Park, S. H., Riley, P.t. & Frisch, S. M. Regulation of anoikis by deleted in breast cancer 1 (DBC1) through NF ?B. Apoptosis 18, 949-962 (2013
138. Kamarajugadda, S. et al. Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis. Cell Death Dis. 4, e504 (2013
139. Smit, M. A. & Peeper, D. S. Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 30, 3735-3744 (2011
140. Howe, E. N., Cochrane, D. R. & Richer, J. K. Targets of miR 200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 13, R45 (2011
141. Howe, E. N., Cochrane, D. R., Cittelly, D. M. & Richer, J. K. miR 200c targets a NF ?B up regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS ONE 7, e49987 (2012
142. Bracken, C. P. et al. A double-negative feedback loop between ZEB1 SIP1 and the microRNA 200 family regulates epithelial-mesenchymal transition. Cancer Res. 68, 7846-7854 (2008
143. Burk, U. et al. A reciprocal repression between ZEB1 and members of the miR 200 family promotes EMT and invasion in cancer cells. EMBO Rep. 9, 582-589 (2008
144. Gregory, P. A. et al. The miR 200 family and miR 205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. 10, 593-601 (2008
145. Zhang, X., Zhang, B., Gao, J., Wang, X. & Liu, Z. Regulation of the microRNA 200b (miRNA 200b) by transcriptional regulators PEA3 and ELK 1 protein affects expression of Pin1 protein to control anoikis. J. Biol. Chem. 288, 32742-32752 (2013
146. Ramachandra, M. et al. Restoration of transforming growth factor β signaling by functional expression of smad4 induces anoikis. Cancer Res. 62, 6045-6051 (2002
147. Lallemand, F. et al. Smad7 inhibits the survival nuclear factor ?B and potentiates apoptosis in epithelial cells. Oncogene 20, 879-884 (2001
148. Horowitz, J. C. et al. Combinatorial activation of FAK and AKT by transforming growth factor β1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 19, 761-771 (2007
149. Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D. & Schiemann, W. P. TGF-β upregulates miR 181a expression to promote breast cancer metastasis. J. Clin. Invest. 123, 150-163 (2013